PHARMACEUTICAL COMPOSITION COMPRISING N-PROPYLNORAPOMORPHINE AND CATHECOL-O-METHYL-TRANSFERASE INHIBITOR FOR TREATING PARKINSON'S DISEASE

摘要

A medicament is disclosed for treating Parkinson's disease which is in the form of a pack comprising a dosage of N-propyl norapomorphine (NPA) physiologically acceptable salts or prodrugs thereof and a dosage of a catechol-O-methyl-transferase (COMT) inhibitor.